Hematopoietic Stem Cell Transplant in primary immunodeficiencies

Specialty: Immunology

Recommendations:

IVIG is recommended in PID patients undergoing stem cell transplant.

Dose:

0.4 to 0.6 g/kg/every 3-4 weeks; requirements may increase and should be based on clinical outcome.